osimertinib
astrazeneca
['lung', 'adaura', 'nsclc', 'sclc', 'aura ,(-laura)']
groundbreaking results from the adaura trial today at #asco2023 plenary session #nsclc #lungcancer day 3 
MD, University of Milan. Medical Oncology resident, National Cancer Institute, Milan